10/29/2024 | Press release | Distributed by Public on 10/29/2024 15:28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Ensysce Biosciences, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
293602405
(CUSIP Number)
October 22, 2024
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ |
Rule 13d-1(b) |
☒ |
Rule 13d-1(c) |
☐ |
Rule 13d-1(d) |
* |
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 293602405
1 |
NAMES OF REPORTING PERSONS Perceptive Advisors LLC |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐ |
|
3 |
SEC USE ONLY |
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 |
SOLE VOTING POWER 0 |
||
6 |
SHARED VOTING POWER 1,300,000 |
|||
7 |
SOLE DISPOSITIVE POWER 0 |
|||
8 |
SHARED DISPOSITIVE POWER 1,300,000 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,300,000 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐ |
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.7% |
|
12 |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA |
CUSIP No. 293602405
1 |
NAMES OF REPORTING PERSONS Joseph Edelman |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐ |
|
3 |
SEC USE ONLY |
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION United States of America |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 |
SOLE VOTING POWER 0 |
||
6 |
SHARED VOTING POWER 1,300,000 |
|||
7 |
SOLE DISPOSITIVE POWER 0 |
|||
8 |
SHARED DISPOSITIVE POWER 1,300,000 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,300,000 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐ |
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.7% |
|
12 |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN |
CUSIP No. 293602405
1 |
NAMES OF REPORTING PERSONS Perceptive Life Sciences Master Fund, Ltd. |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐ |
|
3 |
SEC USE ONLY |
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 |
SOLE VOTING POWER 0 |
||
6 |
SHARED VOTING POWER 1,300,000 |
|||
7 |
SOLE DISPOSITIVE POWER 0 |
|||
8 |
SHARED DISPOSITIVE POWER 1,300,000 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,300,000 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐ |
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.7% |
|
12 |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO |
Item 1(a). |
Name of Issuer: |
Ensysce Biosciences, Inc. (the "Issuer")
Item 1(b). |
Address of Issuer's Principal Executive Offices: |
7946 Ivanhoe Avenue, Suite 201
La Jolla, California 92037
Item 2(a). |
Names of Persons Filing: |
The names of the persons filing this report (collectively, the "Reporting Persons") are:
Perceptive Advisors LLC ("Perceptive Advisors")
Joseph Edelman ("Mr. Edelman")
Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund")
Item 2(b). |
Address of Principal Business Office or, if None, Residence: |
The address of the principal business office of each of the Reporting Persons is:
51 Astor Place, 10th Floor
New York, NY 10003
Item 2(c). |
Citizenship: |
Perceptive Advisors is a Delaware limited liability company
Mr. Edelman is a United States citizen
The Master Fund is a Cayman Islands corporation
Item 2(d). |
Title of Class of Securities: |
Common Stock, par value $0.0001 per share ("Common Stock")
Item 2(e). |
CUSIP Number: |
293602405
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
Item 4. |
Ownership. |
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Schedule 13G. The ownership percentages reported are based on 14,914,118 shares of Common Stock outstanding as of October 16, 2024, as reported by the Issuer in its Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 18, 2024.
Neither Perceptive Advisors nor Mr. Edelman directly holds any Common Stock. The Master Fund directly holds 1,300,000 shares of Common Stock. Perceptive Advisors serves as the investment manager to the Master Fund. Mr. Edelman is the managing member of Perceptive Advisors.
Item 5. |
Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable.
Item 7. |
Identification and Classification of the SubsidiaryWhich Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not applicable.
Item 8. |
Identification and Classification of Members of the Group. |
Not applicable.
Item 9. |
Notice of Dissolution of Group. |
Not applicable.
Item 10. |
Certification. |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Date: | October 29, 2024 | |
PERCEPTIVE ADVISORS LLC | ||
By: |
/s/ Joseph Edelman |
|
Name: Joseph Edelman | ||
Title: Managing Member | ||
/s/ Joseph Edelman |
||
JOSEPH EDELMAN | ||
PERCEPTIVE LIFE SCIENCES MASTER FUND, LTD. | ||
By: | Perceptive Advisors LLC | |
By: |
/s/ Joseph Edelman |
|
Name: Joseph Edelman | ||
Title: Managing Member |